The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2018

Filed:

Oct. 12, 2012
Applicant:

Premier Dental Products Company, Plymouth Meeting, PA (US);

Inventors:

William A. McHale, Collegeville, PA (US);

Dale G. Brown, Wharton, TX (US);

Assignee:

Premier Dental Products Company, Plymouth Meeting, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/09 (2006.01); A61K 31/122 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 9/06 (2006.01); A61K 31/593 (2006.01); A61C 15/04 (2006.01); A61C 19/06 (2006.01); A61K 8/34 (2006.01); A61K 8/67 (2006.01); A61Q 11/00 (2006.01); A61K 8/891 (2006.01); A61K 8/90 (2006.01);
U.S. Cl.
CPC ...
A61K 31/09 (2013.01); A61C 15/041 (2013.01); A61C 19/063 (2013.01); A61K 8/345 (2013.01); A61K 8/67 (2013.01); A61K 8/891 (2013.01); A61K 8/90 (2013.01); A61K 9/006 (2013.01); A61K 9/0063 (2013.01); A61K 9/06 (2013.01); A61K 31/122 (2013.01); A61K 31/593 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61Q 11/00 (2013.01);
Abstract

A topical vitamin D and UBIQUINOL supplement composition useful in treating oral inflammation and reducing oxidative stress comprising: a supplement mixture of vitamin D and UBIQUINOL in an aqueous-free emulsion containing: spilanthes extract, stabilizing compositions for UBIQUINOL and trans-oral mucosal absorption facilitators for the supplement mixture; where the emulsion forms a mucoadhesive gel in the presence of saliva, that effects passive diffusion through the oral mucosa of the supplement mixture and spilanthes extract regulating: in vivo availability and immune response of the supplement mixture, and maintaining adequate levels of circulating vitamin D and of adjunctively administered UBIQUINOL, while minimizing the risk of hypercalcemia.


Find Patent Forward Citations

Loading…